Fifteen years of subcutaneous implantable cardioverter-defibrillator therapy: Where do we stand, and what will the future hold? Posted on July 15th, 2024 by LEADconnection Post navigation Previous: Syncope Due to Iatrogenic Cava Vein Obstruction: Rare Complication of Cardiac Implantable Electronic Device Leads.Next: First-in-man clinical implantation and acute pacing performance of a novel subxiphoidal pacemaker system.
Severe Tricuspid Regurgitation in a Patient with a Transvenous Dual-chamber Pacemaker: Considerations for Diagnosis and Management. Posted on July 15th, 2024 by LEADconnection Post navigation Previous: Concurrent lead impedance reduction in both leads of a dual-chamber pacemaker secondary to generator defect.Next: Syncope Due to Iatrogenic Cava Vein Obstruction: Rare Complication of Cardiac Implantable Electronic Device Leads.
MRI in Patients with Cardiovascular Implantable Electronic Devices and Fractured or Abandoned Leads. Posted on July 15th, 2024 by LEADconnection Post navigation Previous: Advancements in Finite Element Modeling for Cardiac Device Leads and 3D Heart Models.Next: A screw-type pacemaker lead implanted in the right atrium perforated the ascending aorta.
